Surrogacy Market Synopsis
Surrogacy Market Size Was Valued at USD 38.2 Billion in 2023 and is Projected to Reach USD 276.52 Billion by 2032, Growing at a CAGR of 24.6% From 2024-2032.
Surrogacy is a form of childbearing in which a woman (the surrogate mother) consents to bear and give birth to a child for another person or couple of the intended parents. In this process, the surrogate has to get pregnant through techniques that include IVF or artificial insemination with the aim of giving up the child after birth to the intended user.
- Surrogacy can be classified into two main types: The two types of surrogacy are; the traditional surrogacy, and the gestational surrogacy. Ingestine surrogacy, the woman who will be carrying the child also donates the eggs which means that she will be the biological mother of the child. Gestational surrogacy is also known as genetic surrogacy where the surrogate has no genetic link with the child as the child’s creation involves the gametes of the intended parents or donors.
- Generally, gestational surrogacy is the most practiced type of surrogacy in present day practice due to the fact that it does away with legal and psychological issues apparent in traditional surrogacy. This involves the intended parents or the donors in as much as they offer the genetic material. The classified egg is artificially fertilized to ensure the formation of an embryo and the same is inserted into the surrogate’s womb. During the pregnancy, the surrogate gets all the necessary medications and emotional backing, the state of the fetus and the surrogate is checked often. Upon the birth of a baby, legal action is taken by the intended parents’ solicitor to obtain an order of the court granting the intended parents legal parenthood of the child, this is usually done through either a pre birth or post birth order depending on the law of the country.
- The laws of surrogacy are quite different in different parts of the world: there are countries that have rather comprehensively thought out the legal disabilities of surrogate motherhood, and countries that recognize surrogacy at all. When surrogacy is legal in a certain country legal contracts between the surrogate, and the intended parents are vital. These agreements address most issues that may arise in the marriage, including, among others, medical issues, compensation, and parenting issues. Besides, the ethical issue gives a great contribution to the surrogacy discourse.
- Surrogacy is not only a medical and legal procedure but is also has psychological aspect for the surrogate, Intended parents and for the bambino. Some surrogates claim that the overwhelming reward is of feeling that they have made others gain parenthood and this is the reason why they agree to act as surrogates but in most cases they have to deal with certain physical and psychological problems during the pregnancy and some time after the birth of the child. In contrast, intended parents may have hope, anxiety and joyful moments while going through the intended surrogate process.
Surrogacy Market Trend Analysis
Focus on Surrogate Well-being
- Surrogate well-being shift is considered as one of the changes in the market of surrogacy while taking into attention more general social and ethical questions. The above trends reveal the need for proper treatment of surrogates, who are relevant to the process. Traditionally, there have been complaints about the surrogate industry as the clients’ needs have been given preference over the surrogate’s needs. Nevertheless, the increasing rates of awareness or rather advocacy have to some extent ensured stricter measures to ensue the safety of the surrogate’s body, mind, and wallet.
- This development process has also demonstrated that there is a concern in legal and medical provisions to ensure that surrogates’ health is protected. This includes matters to do with frequent medical exams, issues on counselling and very specific legal agreements on their status and roles as stipulated in the constitution. Surrogates receive better healthcare and counselling services in clinics and agencies throughout the surrogacy process as agencies and clinics continue to improve the surrogates’ quality services. Such steps assist in protection of the surrogates in terms of health both during and after pregnancy as well as the provision of adequate care for recovery.
- Also, to the economic aspect of surrogates more attention is paid. The cost for clinical services, fees for services, financial terms concerning payments, and insurance in the event of pregnancies complications are increasingly forming part of standard practice. It also ensures that surrogates are financially if not otherwise taken care of and at the same time, help in developing a standard for ethical surrogacy. In this regard, the industry aims at improving the surrogates’ welfare, which goes a long way in changing the overall outlook and making the model humane for everyone – the commissioning parents and the children who are bound to be born through such arrangements.
Technology-Driven Solutions
- Technological solutions are and may be reshaping the surrogacy landscape by offering new approaches and a convenient means of matching intended parents, surrogates, and fertility clinics. Besides, there is a notable development in the availability of Internet-based services and applications that help through the entire journey of surrogacy. These helps in arranging intended parents with suitable surrogates through the selection on the basis of the desirable attributes infact medical, legal and the societal norms. These platforms also introduce the ability to utilize data analytics and machine learning to further increase the speed and accuracy that is present in this identification process whereas traditional methods take far more time and effort.
- As for other related services, rapid technological advancement in the field of surrogacy is improving communication and assistance throughout the process. Virtual consultations with fertility specialists, psychologists, and lawyers are possible through telehealth services; this means that intended parents and surrogates do not have to physically be in the same place as their service providers. On the same note, this convenience apart from sparing time and costs of traveling guarantees constant support and directions from the respective parties throughout the process. In addition, the use of mobile applications guarantees timely notifications, alerts, and materials for all the stakeholders, which creates trust.
- Besides, the high-technological medical approaches are also helpful in enhancing the surrogacy results. Advent of technology in the field of reproductive health, in person to IVF technology, brings better success rates and healthier pregnancy. Possible methods help to freeze the embryos and store them which creates more potential choices for becoming parents for intended parents. Also, for protection of electronic medical records and legal contracts, the use of blockchain is being researched. All these technological features taken together, therefore help in making surrogacy more available, enhanced and safer for all the players in the market.
Surrogacy Market Segment Analysis:
Surrogacy Market Segmented based on Type, Technology, and Service Provider.
By Type, Gestational surrogacy is expected to dominate the market during the forecast period
- In surrogacy, gestational surrogacy is the most popular in the market and widely accepted. This type of surrogacy is where the embryo, through the fertilization of the intended parent’s or donor egg and sperm is transferred into the surrogate’s womb. The surrogate, thus, does not share any blood type with the child she helps to bear. The main reason therefore, why gestational surrogacy is largely practiced is because it is socially and legally acceptable. Most countries/states that have legalised surrogate motherhood prefer or only allow for gestational surrogate motherhood as it does not pose so much of a role clarity problem leading to a battle between the surrogate mother and the intended parents over the rights of the child.
- Gestational surrogacy is also preferred by more intended parents because of the developments in ART practice like IVF. All of these have enhanced the chances of success and thus gestational surrogacy has turned out to be more feasible. Furthermore, intended parents prefer gestational surrogacy since in this type of surrogacy, their own genes can be used for the creation of a child. oh, this genetic connection is especially valuable for those, who struggle with infertility, those, who are gay, or those, who are single but want to have a kid.
- Moreover, gestational surrogacy provides more options as regards sourcing the eggs and sperm of the child to be surrogated. If intended parents cannot utilize their own eggs or sperm, then it is possible to look for a donor and thus increase the options for becoming a parent significantly. This allows gestational surrogacy to become popular among more individuals due to the legal determination and higher rates of achieving success, which are the reasons for the dominance of gestational surrogacy in the market. In contrast, the kind of surrogate where the woman also donates an egg in her own right, is more laden with emotional and legal entrails and therefore is not as popular.
By Technology, In-vitro fertilization (IVF) segment held the largest share
- When it comes to the technologies that are employed in assisting reproductive legislation within the surrogate arrangements, IVF is the most prominent among all the ART. IVF here means that an egg is fertilized outside the body generally in a laboratory and an embryo is then placed into the surrogate’s womb. The said technique is preferred in surrogacy for the following reasons. First, IVF is very effective and its efficacy depends on the approximated success of the procedure determined by the age and medical condition of the egg donor or the individual who wants to become a parent. This reliability in the formation of successful pregnancies makes it an option that is well appreciated from the surrogates’ side as well as from the intended parents hoping to get the best of the deal.
- Besides, IVF can use a wide variety of genetic material; this means that it is not rigid in its choice of genetic material. Everyone can select the option of IVF using one’s Genetic Material where intended parents can use their gametes or if required, use donor gametes and thus, surrogacy is available to a lot more people/ couples. This flexibility is important in handle with the different fertility concerns, such as those that involve genetic condition or infertility which will require the employment of donor germ cells.
- Other ART techniques, which can also be employed to assist in fertility treatments include IUI, ICSI, and others, their use in surrogacy is comparatively much lesser than IVF. For instance, IUI means the sperm are washed and placed in the uterus during the ovulation and is used in simple cases of infertility. Intracytoplasmic sperm injection or ICSI is mostly employed in association with IVF in order to boost the rates of fertilization but is not frequently employed in standard surrogacy practices. Thus, due to its efficiency, applicability, as well as a proven non-trivial effectiveness rating, IVF technology is the most focused method in a surrogacy market that ensures the expectation of successful pregnancy through assisted reproduction.
Surrogacy Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast Period
- There are many reasons why North America leads in surrogacy market. To begin with, there is sufficient legal framework that governs and recognizes surrogacy explicitly across the globe especially the list countries such as the United States and Canada. Most of the states in the U. S. have legal regulations that govern surrogate mothers’ rights as well as those of the intended parents making it secure. Due to this legal recognition, surrogate mothers and intended parents both from the United States and from other countries apply to the relevant Agencies to undertake a legal and non-illegal surrogacy process.
- Region is endowed with good health facilities and doctors who play vital roles in surrogacy processes. It is indeed an excellent place specifically for those individuals who are seeking infertility treatments as there are many clinics and doctors that provide patients with the up-to-date methods as well as impressive outcomes. This is because medical services in most western countries are world-class; it means that surrogates and intended parents are bound to receive quality health care throughout the pregnancy and birth period. This is a rather high level of medical care, and it is one of the main attractions for intended parents from around the world.
- The socio – economic conditions in North America foster the surrogacy business. Several of the expected surrogates may be drawn by the financial remuneration provided, which is fairly viable income addition in most cases. Zion et al (2011) also report that there is no social prejudice towards surrogacy and everyone is embracing assisted reproductive technologies, more women are thus coming forward to act as surrogates. Due to the issues of laws, medicines and social and economic factors North America has become a favored place for people in search of surrogate services.
Active Key Players in the Surrogacy Market
- An IVF Clinic (Greece)
- CARE Surrogacy Center Mexico (Mexico)
- Circle Surrogacy & Egg Donation (USA)
- Conceptual Options LLC (USA)
- Extraordinary Conceptions (USA)
- Family Source Consultants (USA)
- Fertility Center of California (USA)
- Global Surrogacy Services (USA)
- Growing Generations (USA)
- IARC Surrogacy (USA)
- International Fertility Group (Canada)
- IVF New Jersey Fertility Center (USA)
- IVI-RMA Global (Spain)
- New Life Global Network (Georgia)
- Simple Surrogacy (USA)
- Southern Surrogacy (USA)
- Surrogacy America (USA)
- Surrogate Alternatives, Inc. (USA)
- Tammuz Family (Israel)
- The Surrogacy Institute (USA)
- Other Key Players
Global Surrogacy Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 38.2 Bn. |
Forecast Period 2023-34 CAGR: |
24.6 % |
Market Size in 2032: |
USD 276.52 Bn. |
Segments Covered: |
By Type |
|
|
By Technology |
|
||
By Service Provider |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Surrogacy Market by Type
4.1 Surrogacy Market Snapshot and Growth Engine
4.2 Surrogacy Market Overview
4.3 Gestational Surrogacy
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Gestational Surrogacy: Geographic Segmentation Analysis
4.4 Traditional Surrogacy
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Traditional Surrogacy: Geographic Segmentation Analysis
Chapter 5: Surrogacy Market by Technology
5.1 Surrogacy Market Snapshot and Growth Engine
5.2 Surrogacy Market Overview
5.3 Intrauterine insemination (IUI)
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Intrauterine insemination (IUI): Geographic Segmentation Analysis
5.4 In-vitro fertilization (IVF)
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 In-vitro fertilization (IVF): Geographic Segmentation Analysis
5.5 Classical/standard IVF
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Classical/standard IVF: Geographic Segmentation Analysis
5.6 Intracytoplasmic sperm injection (ICSI)
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Intracytoplasmic sperm injection (ICSI): Geographic Segmentation Analysis
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation Analysis
Chapter 6: Surrogacy Market by Service Provider
6.1 Surrogacy Market Snapshot and Growth Engine
6.2 Surrogacy Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation Analysis
6.4 Fertility clinics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Fertility clinics: Geographic Segmentation Analysis
6.5 Others
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Others: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Surrogacy Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 AN IVF CLINIC (GREECE)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 CARE SURROGACY CENTER MEXICO (MEXICO)
7.4 CIRCLE SURROGACY & EGG DONATION (USA)
7.5 CONCEPTUAL OPTIONS LLC (USA)
7.6 EXTRAORDINARY CONCEPTIONS (USA)
7.7 FAMILY SOURCE CONSULTANTS (USA)
7.8 FERTILITY CENTER OF CALIFORNIA (USA)
7.9 GLOBAL SURROGACY SERVICES (USA)
7.10 GROWING GENERATIONS (USA)
7.11 IARC SURROGACY (USA)
7.12 INTERNATIONAL FERTILITY GROUP (CANADA)
7.13 IVF NEW JERSEY FERTILITY CENTER (USA)
7.14 IVI-RMA GLOBAL (SPAIN)
7.15 NEW LIFE GLOBAL NETWORK (GEORGIA)
7.16 SIMPLE SURROGACY (USA)
7.17 SOUTHERN SURROGACY (USA)
7.18 SURROGACY AMERICA (USA)
7.19 SURROGATE ALTERNATIVES
7.20 INC. (USA)
7.21 TAMMUZ FAMILY (ISRAEL)
7.22 THE SURROGACY INSTITUTE (USA)
7.23 OTHER KEY PLAYERS
Chapter 8: Global Surrogacy Market By Region
8.1 Overview
8.2. North America Surrogacy Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Type
8.2.4.1 Gestational Surrogacy
8.2.4.2 Traditional Surrogacy
8.2.5 Historic and Forecasted Market Size By Technology
8.2.5.1 Intrauterine insemination (IUI)
8.2.5.2 In-vitro fertilization (IVF)
8.2.5.3 Classical/standard IVF
8.2.5.4 Intracytoplasmic sperm injection (ICSI)
8.2.5.5 Others
8.2.6 Historic and Forecasted Market Size By Service Provider
8.2.6.1 Hospitals
8.2.6.2 Fertility clinics
8.2.6.3 Others
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Surrogacy Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Type
8.3.4.1 Gestational Surrogacy
8.3.4.2 Traditional Surrogacy
8.3.5 Historic and Forecasted Market Size By Technology
8.3.5.1 Intrauterine insemination (IUI)
8.3.5.2 In-vitro fertilization (IVF)
8.3.5.3 Classical/standard IVF
8.3.5.4 Intracytoplasmic sperm injection (ICSI)
8.3.5.5 Others
8.3.6 Historic and Forecasted Market Size By Service Provider
8.3.6.1 Hospitals
8.3.6.2 Fertility clinics
8.3.6.3 Others
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Bulgaria
8.3.7.2 The Czech Republic
8.3.7.3 Hungary
8.3.7.4 Poland
8.3.7.5 Romania
8.3.7.6 Rest of Eastern Europe
8.4. Western Europe Surrogacy Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Type
8.4.4.1 Gestational Surrogacy
8.4.4.2 Traditional Surrogacy
8.4.5 Historic and Forecasted Market Size By Technology
8.4.5.1 Intrauterine insemination (IUI)
8.4.5.2 In-vitro fertilization (IVF)
8.4.5.3 Classical/standard IVF
8.4.5.4 Intracytoplasmic sperm injection (ICSI)
8.4.5.5 Others
8.4.6 Historic and Forecasted Market Size By Service Provider
8.4.6.1 Hospitals
8.4.6.2 Fertility clinics
8.4.6.3 Others
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 Netherlands
8.4.7.5 Italy
8.4.7.6 Russia
8.4.7.7 Spain
8.4.7.8 Rest of Western Europe
8.5. Asia Pacific Surrogacy Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Type
8.5.4.1 Gestational Surrogacy
8.5.4.2 Traditional Surrogacy
8.5.5 Historic and Forecasted Market Size By Technology
8.5.5.1 Intrauterine insemination (IUI)
8.5.5.2 In-vitro fertilization (IVF)
8.5.5.3 Classical/standard IVF
8.5.5.4 Intracytoplasmic sperm injection (ICSI)
8.5.5.5 Others
8.5.6 Historic and Forecasted Market Size By Service Provider
8.5.6.1 Hospitals
8.5.6.2 Fertility clinics
8.5.6.3 Others
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Surrogacy Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Type
8.6.4.1 Gestational Surrogacy
8.6.4.2 Traditional Surrogacy
8.6.5 Historic and Forecasted Market Size By Technology
8.6.5.1 Intrauterine insemination (IUI)
8.6.5.2 In-vitro fertilization (IVF)
8.6.5.3 Classical/standard IVF
8.6.5.4 Intracytoplasmic sperm injection (ICSI)
8.6.5.5 Others
8.6.6 Historic and Forecasted Market Size By Service Provider
8.6.6.1 Hospitals
8.6.6.2 Fertility clinics
8.6.6.3 Others
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkey
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Surrogacy Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Type
8.7.4.1 Gestational Surrogacy
8.7.4.2 Traditional Surrogacy
8.7.5 Historic and Forecasted Market Size By Technology
8.7.5.1 Intrauterine insemination (IUI)
8.7.5.2 In-vitro fertilization (IVF)
8.7.5.3 Classical/standard IVF
8.7.5.4 Intracytoplasmic sperm injection (ICSI)
8.7.5.5 Others
8.7.6 Historic and Forecasted Market Size By Service Provider
8.7.6.1 Hospitals
8.7.6.2 Fertility clinics
8.7.6.3 Others
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
Global Surrogacy Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 38.2 Bn. |
Forecast Period 2023-34 CAGR: |
24.6 % |
Market Size in 2032: |
USD 276.52 Bn. |
Segments Covered: |
By Type |
|
|
By Technology |
|
||
By Service Provider |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Frequently Asked Questions :
The forecast period in the Surrogacy Market research report is 2024-2032.
An IVF Clinic (Greece), CARE Surrogacy Center Mexico (Mexico), Circle Surrogacy & Egg Donation (USA), Conceptual Options LLC (USA), Extraordinary Conceptions (USA), Family Source Consultants (USA), Fertility Center of California (USA), Global Surrogacy Services (USA), Growing Generations (USA), IARC Surrogacy (USA), International Fertility Group (Canada), IVF New Jersey Fertility Center (USA), IVI-RMA Global (Spain), New Life Global Network (Georgia), Simple Surrogacy (USA), Southern Surrogacy (USA), Surrogacy America (USA), Surrogate Alternatives, Inc. (USA), Tammuz Family (Israel), The Surrogacy Institute (USA) and Other Major Players.
The Surrogacy Market is segmented into Type, Technology, Service Provider and region. By Type, the market is categorized into Gestational surrogacy, Traditional surrogacy. By Technology, the market is categorized into Intrauterine insemination (IUI), In-vitro fertilization (IVF), Classical/standard IVF, Intracytoplasmic sperm injection (ICSI) and Other. By Service Provider, the market is categorized into Hospitals, Fertility clinics, Others. By region, it is analyzed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain, etc.), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
Surrogacy can be defi ned as the practice in which a woman, referred to as a surrogate, willingly undertakes to become pregnant and give birth to a child for another person or couple, who are known as intended parents. This kind can be gestational where the surrogate does not share any related genetic material with the child or it can be the traditional kind where the surrogate’s egg is used. Surrogacy is meant to give a hope of a family for those people who cannot have a genetic child on their own due to reasons such as infertility, medical conditions or other reasons that do not allow them to get pregnant and/or give birth.
Surrogacy Market Size Was Valued at USD 38.2 Billion in 2023, and is Projected to Reach USD 276.52 Billion by 2032, Growing at a CAGR of 24.6% From 2024-2032.